Abstract: The disclosed invention generally relates to pharmaceutical compounds and methods for treating and/or preventing diseases and disorders that often manifest in hyper and/or hypokinetic movements symptoms, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids to subjects in need of treatment. The disclosed invention further relates to cannabinoid pharmaceutical compounds where said compound contains at least some non-cannabinoid components.

Abstract: The disclosed invention generally relates to pharmaceutical compounds and methods for treating and/or preventing diseases and disorders that often manifest in hyper and/or hypokinetic movements symptoms, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids to subjects in need of treatment. The disclosed invention further relates to cannabinoid pharmaceutical compounds where said compound contains at least some non-cannabinoid components.

Abstract: The disclosed invention generally relates to pharmaceutical and nutraceutical compounds and methods for reducing inflammation, muscle spasms, and pain associated with cancer, trauma, medical procedure, neurological diseases and disorders, as well as other conditions in subjects in need thereof. The disclosed invention further relates to Mitragyna speciose and Cannabis sativa based compounds and synthetic analogs of the alkaloids found in said plants, where said compounds can also contain a pharmacologically inactive substance for modifying certain qualities of said compounds.

Abstract: The disclosed invention generally relates to pharmaceutical compounds and methods for treating and/or preventing diseases and disorders that often manifest in hyper and/or hypokinetic movements symptoms, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids to subjects in need of treatment. The disclosed invention further relates to cannabinoid pharmaceutical compounds where said compound contains at least some non-cannabinoid components.

Abstract: The disclosed invention generally relates to pharmaceutical and nutraceutical compounds and methods for reducing neuropathic pain and depression caused by toxicity, metabolism abnormality, trauma, compression, autoimmune abnormality, congenital/hereditary abnormality, infection, abnormally activated neuronal circuits, emotional stress, chemical imbalance, mental health disorder, or other causes in subjects in need thereof. The disclosed invention further relates to naturally occurring, synthetic and semi-synthetic multifunctional compounds that exhibit antidepressant and analgesic activity where said compound contains a pharmacologically inactive substance.

Abstract: The disclosed invention generally relates to pharmaceutical compounds and methods for treating and/or preventing diseases and disorders that often manifest in hyper and/or hypokinetic movements symptoms, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids to subjects in need of treatment. The disclosed invention further relates to cannabinoid pharmaceutical compounds where said compound contains at least some non-cannabinoid components.

Abstract: The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.

Abstract: The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.

Abstract: The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.

Abstract: The present invention relates to pharmaceutical and nutraceutical compounds and methods for reducing inflammation, blood sugar, gastric acid, symptoms of allergy, common cold and flu, as well as treating infections and pain associated with trauma, medical procedure, and diseases and disorders in subjects in need thereof. The compounds and methods proposed by this invention are related to essentially a mixture of naturally accruing and/or synthetic substances in certain ratios, administration protocols, and delivery systems that amplify their medicinal qualities and reduce side effects, making their clinical application feasible.

Abstract: The disclosed invention generally relates to pharmaceutical and nutraceutical compounds and methods for reducing inflammation, muscle spasms, and pain associated with cancer, trauma, medical procedure, neurological diseases and disorders, as well as other conditions in subjects in need thereof. The disclosed invention further relates to Mitragyna speciose and Cannabis sativa-based compounds and synthetic analogs of the alkaloids found in said plants, where said compounds can also contain a pharmacologically inactive substance for modifying certain qualities of said compounds.

Abstract: The disclosed invention generally relates to pharmaceutical and nutraceutical compounds and methods for reducing appetite, muscle fatigue and spasticity, enhancing athletic performance, and treating pain associated with cancer, trauma, medical procedure, and neurological diseases and disorders in subjects in need thereof. The disclosed invention further relates to Kratom compounds where said compound contains at least some pharmacologically inactive component.

Abstract: The disclosed invention includes methods and systems for performing audio-aided data collection and retrieval, where the data collection and retrieval is related to one or more persons, or subjects or objects associated with one or more persons. The data collection and retrieval is performed with a help of audio data that contains at least some human audio biometrics or non-human audio characteristics and some annotation data of said audio data. The data collection and retrieval involves: audio data and annotation collection, audio data analysis and searching for similar audio data or its product, data searching and processing, results aggregation and presentation, and optional collection of feedback.

Abstract: The disclosed invention includes a method and a system for performing image-aided data collection and retrieval, where the data collection and retrieval is related to one or more persons, or subjects or objects associated with one or more persons. The data collection and retrieval is performed with the help of one or more images that contain one or more objects of interest and at least some annotation data related to at least one object of interest. The data collection and retrieval involves: image and annotation collection, image analysis and searching for similar images, data searching and processing, results aggregation and presentation, and optionally collection of feedback.

Abstract: The disclosed invention in essence relates to protection of information in communication channels between a sender and a communication server and a communication server and a receiver, and wherein a Vernam cypher and one time pad personal encryption keys of a sender and a receiver are used for encrypting transmitted data.

Abstract: The present disclosure provides method and apparatus for protecting data transmitted in the communication channels between plurality of sender-devices and plurality of receiver-devices. The protection is achieved by using encryption with one-time-pad encryption keys, where such keys are distributed using one or more special media servers, and the protection of communications between such media server and plurality of devices is achieved using personal one-time-pad keys.

Abstract: The method of location tracking of a computing device (computer, notebook, mobile phone, etc.) that can be used to prevent unauthorized access and/or theft of the device. The essence of the invention is that special software is installed on the computing device that can obtain external and internal IP-addresses of the Internet enabled computing device. The special software then processes this information and forms an electronic massage that includes IP-addresses and an identifier of the computing device. Special software then sends this message to an electronic address preset by the user of the computing device. Only the user of the computing device and the special software installed on the computing device has access to such electronic address.